Simris Alg announces change of Certified Adviser to Amudova and termination of liquidity guarantee service

Simris Alg AB hereby announces that the company has entered into an agreement with Amudova AB regarding the service as Certified Adviser. Amduova AB will be appointed Certified Adviser (CA) on July 20, 2022. Up until then, Mangold Fondkommission AB will continue to act as Certified Adviser for the company. Simris Alg AB has also decided to terminate the agreement with Mangold Fondkommission AB regarding liquidity services. The final day with liquidity guarantee will be October 18, 2022.

For further information, please contact:
Julian Read, CEO, Simris Alg AB
Tel: +46 76 788 82 12, e-mail: [email protected]

About Simris Alg
Simris Alg is a pioneering biotechnology company dedicated to the enormous potential of microalgae in the discovery and production of high-quality bioactive substances and alternatives to unsustainable marine ingredients. We are engaged in research, development, and production of bioactive substances from microalgae, for nutraceutical, cosmetic and pharmaceutical applications. Our technology provides access to bioactive substances with new functions, while at the same time replacing unsustainable raw materials from endangered marine species and ecosystems.

Simris Alg’s share is traded on Nasdaq First North Growth Market with the ticker SIMRIS and ISIN-code SE0008091664. Mangold Fondkommission AB is the Company’s Certified Adviser, reachable by tel: 08-503 015 50 and email: [email protected].